Tactile Medical to Release Fourth Quarter and Fiscal Year 2020 Financial Results on February 23, 2021
Tactile Systems Technology (TCMD) will release its fourth quarter and fiscal year 2020 financial results after market close on February 23, 2021. Management will host a conference call at 5:00 p.m. ET on the same day to discuss the financial outcomes and answer questions from participants. Investors can join the call via phone or through a live webcast on their investor relations website. The archived call will be available for two weeks, ensuring that shareholders can review the details of the financial performance and strategic insights shared during the event.
- Company plans to release fourth quarter and fiscal year 2020 financial results, providing transparency to investors.
- Management will host a conference call to discuss results, indicating engagement with shareholders.
- None.
MINNEAPOLIS, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today announced that fourth quarter and fiscal year 2020 financial results will be released after the market closes on Tuesday, February 23.
Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on February 23 to discuss the results of the quarter and the fiscal year. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13715783. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13715783. The webcast will be archived at investors.tactilemedical.com.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical’s Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.
FAQ
What date will Tactile Systems Technology release its Q4 2020 results?
What time is the conference call for TCMD's financial results?
How can I access the webcast of the TCMD conference call?